Skip to main content
. 2022 Feb 28;47(3):419–429. doi: 10.1007/s13318-021-00745-6

Fig. 3.

Fig. 3

Median plasma concentration–time curves (semilog scale) for abrocitinib metabolites M1 (a), M2 (b), and M4 (c) in the presence and absence of probenecid; BID twice daily, SD single dose